Trading for the period was in line with the Board's expectations. The Devro 100 programme continues to progress well, with actions on track to deliver the targeted cost savings for the year. As part of the phased plan to achieve the targeted levels of productivity and output efficiencies at our US plant, good progress was made during the period. Our China plant continues to perform well. As previously indicated our focus now is on improving the pricing for the products from this plant, and progress was made during the period.
Whilst recognising the ongoing pressures from input cost inflation and exchange rate volatility, the Board remains confident that Devro is well placed to make good progress in 2018.